Pretransplant Comorbidities Maintain Their Impact on Allogeneic Stem Cell Transplantation Outcome 5 Years Posttransplant: A Retrospective Study in a Single German Institution

Table 4

Comparison of data with Sorror et al. [7] and Birninger et al. [18].

	Chemnitz et al.	Sorror et al. [7]	Birninger et al. [18]
	245	347	370 (only 340 included)
Median age	45	44.5	53
Related donors (%)	35.5	58	34.1
HCT-CI (low 0)	49 (20%)	132 (38%)	18 (5%)
HCT-CI (intermediate 1, 2)	120 (49%)	118 (34%)	70 (21%)
HCT-CI (High ≥3)	76 (31%)	97 (28%)	252 (74%)
Prevalence of pulmonary comorbidity	27%	34%	34%
Prevalence of cardiac comorbidity	9%	7%	56%
Prevalence of hepatic comorbidity	7%	20%	51%